Doyle Wealth Management Pfizer Inc Transaction History

Doyle Wealth Management

$1.16 Billion
Q3 2022

A detailed history of Doyle Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Doyle Wealth Management holds 480,030 shares of PFE stock, worth $12.8 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares

480,030

Previous 483,895 0.8%

Holding current value

$12.8 Million

Previous $25.4 Million 17.2%

% of portfolio

1.8%

Previous 2.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $169,132 - $206,468	-3,865 Reduced 0.8%	480,030 $21 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $288,718 - $342,329	-6,205 Reduced 1.27%	483,895 $25.4 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $305,701 - $378,802	-6,682 Reduced 1.35%	490,100 $25.4 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $249,944 - $370,501	-6,049 Reduced 1.2%	496,782 $29.3 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $12,010 - $15,428	306 Added 0.06%	502,831 $21.6 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $335,830 - $380,439	9,352 Added 1.9%	502,525 $19.7 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $93,001 - $104,887	-2,777 Reduced 0.56%	493,173 $17.9 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $38,758 - $49,284	1,158 Added 0.23%	495,950 $18.3 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $135,667 - $159,169	4,273 Added 0.87%	494,792 $18.2 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $308,850 - $374,681	-10,254 Reduced 2.05%	490,519 $16 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $42,085 - $60,131	-1,557 Reduced 0.31%	500,773 $16.3 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $299,736 - $340,162	9,105 Added 1.85%	502,330 $19.7 Million
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $26,804 - $34,757	-825 Reduced 0.17%	493,225 $17.7 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $166,077 - $186,466	-4,491 Reduced 0.9%	494,050 $21.4 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $257,287 - $282,673	6,861 Added 1.4%	498,541 $20.3 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $1.08 Million - $1.23 Million	-28,131 Reduced 5.41%	491,680 $21.5 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $100,376 - $121,750	2,912 Added 0.56%	519,811 $22.9 Million
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $1.35 Million - $1.44 Million	40,947 Added 8.6%	516,899 $18.8 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $119,279 - $138,380	3,738 Added 0.79%	475,952 $16.9 Million
Q4 2017 Feb 07, 2018	SELL	$33.26 - $35.29 $375,937 - $398,882	-11,303 Reduced 2.34%	472,214 $17.1 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $15 Million - $16.5 Million	483,517	483,517 $17.3 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Account

Doyle Wealth Management Pfizer Inc Transaction History